← All compounds
peptide30 listings
Liraglutide
GLP-1 Agonist (Daily)
Daily-dosed GLP-1 agonist. FDA approved.
Metabolic researchWeight research
/ research index
The research base
Research Maturity
★★★★★
5/5 — Volume of studies
Evidence Strength
★★★★★
5/5 — Quality of evidence
Multiple Phase 3 trials. FDA approved.
/ mechanism of action
How it works
GLP-1 receptor agonist.
/ research dosing
Common research protocols
Range
0.6 → 1.2 → 1.8 → 2.4 → 3.0 mg/day (titration)
Frequency
Once daily
Route
Subcutaneous
Cycle
Continuous after titration
Research notes
Saxenda titration: increase 0.6mg weekly to maintenance 3.0mg/day. Daily injection (not weekly like newer GLP-1s).
References
FDA Saxenda label
FOR RESEARCH USE ONLY. Doses listed are compiled from published research literature, FDA-approved drug labels, and well-documented research community practice. Not medical advice.
/ standalone use
As a solo compound
Standalone use is the standard.
/ side effects
What to know
Common: GI adjustment.
/ timeline
Realistic expectations
4-12 weeks
/ recommendation
Where to buy Liraglutide
🏆Our pick for Liraglutide
Valor Peptides
18mg · USA · Card / Crypto
- ✓Third-party tested (Janoshik)
- ✓COAs provided — Comprehensive
- ✓Highest verification tier in stock
- ✓4.8★ community rating
Also solid
/ all listings
Full index, price per mg
Supplier
Trust Score
Size
Price
$/mg
Stock
Buy
FOR RESEARCH USE ONLY. Liraglutide is intended for laboratory research and not for human consumption.